"A full-service medical center that has provided compassionate health care and quality treatment for more than 20 years."

During the past decade, Littleton Adventist Hospital conducted 154 clinical trials. In the 10-year time frame, 154 clinical trials started and 99 clinical trials were completed, i.e. on average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 66 clinical trials started and 68 clinical trials were completed. i.e. 103% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Littleton Adventist Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 117 trials, followed by "SWOG Cancer Research Network" with 41 trials sponsored, "Alliance for Clinical Trials in Oncology" with 29 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 20 trials sponsored and "NRG Oncology" with 20 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Littleton Adventist Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 120 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Littleton Adventist Hospital" are "Breast Cancer" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Invasive Breast Carcinoma" (8 trials), "Recurrent Breast Carcinoma" (8 trials) and "Recurrent Ovarian Carcinoma" (8 trials). Many other conditions were trialed in "Littleton Adventist Hospital" in a lesser frequency.

Most popular intervention types in "Littleton Adventist Hospital" are "Drug" (194 trials), "Other" (144 trials), "Biological" (111 trials), "Procedure" (56 trials) and "Radiation" (38 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (70 trials), "Quality-of-Life Assessment" (59 trials), "Questionnaire Administration" (39 trials), "Paclitaxel" (32 trials) and "Carboplatin" (30 trials). Other intervention names were less common.

The vast majority of trials in "Littleton Adventist Hospital" are 196 trials for "All" genders, 38 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Littleton Adventist Hospital". undefined are not yet recruiting, 66 are recruiting, 109 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Littleton Adventist Hospital, 3 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Littleton Adventist Hospital, 4 "Phase 1" clinical trials were conducted, 119 "Phase 2" clinical trials and 123 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".

Littleton Adventist Hospital has several departments that took part in Clinical trials: "Hope Cancer Care Center at Longmont United Hospital" - 87 trials, "Longmont United Hospital" - 246 trials